This compound is a prodrug of adefovir, designed to improve oral bioavailability of the parent antiviral agent. It is utilized as a pharmaceutical raw material in the manufacturing of antiviral research compounds.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 323201-04-3
Adefovir Dipivoxil Dimer
pharmaceutical intermediate
ADEFOVIR DIPIVOXIL
antiviral prodrug substance
Sisomicin
aminoglycoside antibiotic
2-Methyl-ethinylestradiol
Active pharmaceutical ingredient
Paroxetine EP Impurity A HCl
active pharmaceutical ingredient
3,4,5-trihydroxy-6-oxooxane-2-carbaldehyde
active pharmaceutical ingredient
[2,2-dimethylpropanoyloxymethoxy-[2-[6-(hydroxymethylamino)purin-9-yl]ethoxymethyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate
YJHTYKJKQVFIIC-UHFFFAOYSA-N
CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)NCO)OCOC(=O)C(C)(C)C